Why It's More Than Just a Human Supplement
Dr. Keith A. Hnilica DVM, MS, MBA, DACVD
6 min read
We often think of melatonin as a human sleep helper, but the science is catching up on our dogs. In people, recent meta-analyses show melatonin makes it easier to fall asleep, lengthens total sleep time (sweet spot near 4 mg), and may even steady nighttime blood pressure for some when used in controlled-release form. It's also being studied as a gentler option to ease pre-surgery jitters and to prevent migraines—all with a generally favorable safety profile.
Why should pet parents care? Because many of the same brain pathways exist in dogs. Recent veterinary reviews and trials report that melatonin can help with noise phobias (storms, fireworks), separation-related anxiety, and even "sundowning"-type cognitive changes in seniors. Importantly, melatonin has a long track record in dermatology for Alopecia X (hair-cycle arrest)—with new controlled studies again showing hair regrowth in affected dogs.
Safety matters across species. In humans, timing and dose are key; in dogs, veterinarians typically use low fixed doses (about 5–20 mg depending on size and goal) and time it 30–120 minutes before a trigger for situational anxiety. Always check labels—xylitol (common in gummies) is toxic to dogs—and talk to your veterinarian if your pet is on other medications or has endocrine issues.
Bottom line: melatonin isn't magic, but it's a low-cost, low-risk tool that can support calmer nights, steadier nerves, and—in certain cases—healthier coats. Pair it with training, sound desensitization, and good sleep hygiene (for you both), and you've got a practical, evidence-informed path to better rest and resilience—human and hound alike.
Better sleep: Dose-response meta-analyses show melatonin shortens the time it takes to fall asleep and increases total sleep time, with benefits peaking around 4 mg per day when properly timed.
Insomnia relief: Recent scoping reviews identify melatonin as one of the most well-studied and generally safe over-the-counter options for adult insomnia.
Perioperative calm: Clinical trials and reviews suggest melatonin can reduce preoperative anxiety and may perform comparably to midazolam while maintaining a favorable safety profile.
ICU sleep and delirium: Systematic reviews indicate melatonin may improve perceived sleep quality and reduce delirium in critically ill adults, although evidence quality remains moderate and variable.
Migraine prevention: Systematic reviews of randomized controlled trials support melatonin as a preventive therapy that may reduce migraine frequency and severity.
Blood pressure support: Contemporary reviews and meta-analyses suggest controlled-release melatonin can lower nighttime and systolic blood pressure. A 2024 meta-analysis also found a small reduction in daytime diastolic blood pressure.
Chemotherapy support: Recent umbrella reviews highlight evidence that melatonin may help lessen certain chemotherapy-related side effects, though research is ongoing.
General clinical guidance: Current clinical overviews continue to support melatonin's role in circadian rhythm and sleep regulation while emphasizing appropriate dosing and potential medication interactions.
